Business
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results before the opening of the U.S. financial markets on Tuesday, May 13, 2025. Management will host a conference call and webcast that day to discuss the Company’s financial and business results. Conference Call & Webcast Detail: Date:Tuesday, May
About this update from Fennec Pharmaceuticals Inc.
[{"type":"image","alt":"Fennec Pharmaceuticals Inc.","displaySize":"","headline":null,"caption":"Fennec Pharmaceuticals Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":121,"height":66,"url":"https://media.zenfs.com/en/globenewswire.com/e01604120df1fa3b9ec5192e4215917f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UkeWnOD1xSZWjTITE4vjkA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTExNTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/e01604120df1fa3b9ec5192e4215917f","width":121,"height":66}},"lazy":false},{"type":"text","content":"RESEARCH TRIANGLE PARK, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its first quarter 2025 financial results before the opening of the U.S. financial markets on Tuesday, May 13, 2025. Management will host a conference call and webcast that day to discuss the Company’s financial and business results.","length":448,"tagName":"p"},{"type":"text","content":"Conference Call & Webcast Detail:","length":37,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"max-width:15%;width:179.516px;min-width:15%;","val":[{"type":"text","content":"Date:","length":5,"tagName":"p","attribs":{}}]},{"style":"max-width:85%;width:1017.3px;min-width:85%;","val":[{"type":"text","content":"Tuesday, May 13, 2025","length":21,"tagName":"p","attribs":{}}]}]},{"val":[{"val":[{"type":"text","content":"Time:","length":5,"tagName":"p"}]},{"val":[{"type":"text","content":"8:30 a.m. ET","length":12,"tagName":"p"}]}]},{"val":[{"val":[{"type":"text","content":"Webcast Link:","length":13,"tagName":"p"}]},{"val":[{"type":"text","content":"https://edge.media-server.com/mmc/p/nb5vbq6o","length":44,"tagName":"p"}]}]},{"val":[{"val":[{"type":"text","content":"Participant Link:","length":17,"tagName":"p"}]},{"val":[{"type":"text","content":"https://register-conf.media-server.com/register/BIbc2eaa3f157d4c6891b71246a83bdb02","length":82,"tagName":"p"}]}]}],"length":199},{"type":"text","content":"To access the live webcast link, log onto www.fennecpharma.com and proceed to the News & Events/Event Calendar page under the Investors & Media heading. Please connect to the company’s website at least 15 minutes prior to the conference call to ensure adequate ti...